DaehanPharmaceutical Logo

DaehanPharmaceutical

Develops and manufactures pharmaceuticals and health foods for human and animal markets worldwide.

023910 | KO

Overview

Corporate Details

ISIN(s):
KR7023910003
LEI:
Country:
South Korea
Address:
서울특별시 영등포구 선유로45길 3, 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Daehan New Pharm Co., Ltd. is a pharmaceutical company that develops, manufactures, and markets a diverse portfolio of healthcare products. Established in 1984 with an initial focus on animal medicine, the company has expanded its operations to four core business areas: human pharmaceuticals, animal pharmaceuticals, biopharmaceuticals, and health functional foods. Its product lines include a range of therapeutic agents, antibiotics, vaccines, and specialized products for both livestock and companion animals. The company places a strong emphasis on innovation, operating dedicated research institutes that focus on next-generation technologies, including cell therapy and anti-aging solutions, for both domestic and international markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-09 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-09-02 00:00
Interim Report
[기재정정]반기보고서 (2025.06)
Korean 840.3 KB
2025-09-01 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 816.8 KB
2025-07-29 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 121.1 KB
2025-05-27 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 770.8 KB
2025-04-21 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-04-11 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.7 KB
2025-04-04 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.7 KB
2025-04-02 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 174.0 KB
2025-03-26 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 18.5 KB
2025-03-21 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 27.0 KB
2025-03-18 00:00
Audit Report / Information
감사보고서제출
Korean 19.0 KB
2025-03-18 00:00
Annual Report
사업보고서 (2024.12)
Korean 956.2 KB

Automate Your Workflow. Get a real-time feed of all DaehanPharmaceutical filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DaehanPharmaceutical

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DaehanPharmaceutical via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Biotech firm using enzyme tech for pharma, healthcare, and bioprocess CDMO services.
South Korea
092040
AMICUS THERAPEUTICS, INC. Logo
Develops advanced therapies for rare lysosomal storage disorders.
United States of America
FOLD
AMINOLOGICS CO.,LTD. Logo
Manufactures high-purity chiral amino acids & APIs for pharma, chemical, and food industries.
South Korea
074430
Amneal Pharmaceuticals, Inc. Logo
Develops & commercializes essential medicines: generics, injectables & specialty drugs.
United States of America
AMRX
Amphastar Pharmaceuticals, Inc. Logo
Develops and manufactures complex injectable, intranasal, and inhalation pharmaceutical products.
United States of America
AMPH
Amylyx Pharmaceuticals, Inc. Logo
Developing novel therapies for neurodegenerative diseases like ALS and Wolfram syndrome.
United States of America
AMLX
AN2 Therapeutics, Inc. Logo
Developing novel small molecule drugs for infectious diseases and oncology using boron chemistry.
United States of America
ANTX
Develops approved cannabinoid medicines for pain, epilepsy, and heart failure.
United Kingdom
ANAN
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapies for autoimmune and inflammatory diseases.
United States of America
ANAB
Develops qPCR diagnostic kits and robotic automation systems for clinical and research laboratories.
Türkiye
ANGEN

Talk to a Data Expert

Have a question? We'll get back to you promptly.